Home > Press > NanoBusiness Alliance Names Lynn L. Bergeson As One of the "Most Influential Nanotechnology Leaders from 2010"
We are pleased to announce that NanoBusiness Alliance (NbA) has selected Lynn L. Bergeson as one of its gMost Influential Nanotechnology Leaders from 2010.h The NbA is the industry association for the emerging nanotechnology industry. Through its extensive network of leading start-ups, Fortune 500 companies, research institutions, non-governmental organizations, and public-private partnerships, the NbA shapes nanotechnology policy and helps accelerate the responsible commercialization of nanotechnology innovation. On July 1, 2010, the NbA issued a Position Statement on Nanomaterials Product Sustainability, which reflects its membersf genduring commitment to managing effectively the environmental, health, and safety (EHS) implications of nanotechnology.h
The NbA states: gLynn is one of Americafs top EH&S practitioners,h and those selected gare all Nanotechnology Evangelists.h The NbA compiled this list from its year-long interview series of influential leaders in the nanotechnology community.
The NbA interview is available online at:
www.vincentcaprio.org/nanobusiness-alliance-interview-lynn-l-bergeson-managing-director-bergeson-campbell-p-c
####
For more information, please click here
Copyright © Bergeson & Campbell
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||